Vistagen Therapeutics, Inc. (VTGN)
0.605
0.00 (0.00%)
USD |
NASDAQ |
Mar 04, 16:00
0.6051
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Research and Development Expense (Annual) : 39.38M for March 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alector, Inc. | 113.40M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 78.03M |
| BioMarin Pharmaceutical, Inc. | 700.97M |